ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

NCT06415487 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Solid Tumor
Metastatic Solid Tumor

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: ACE2016
DRUG: Pembrolizumab

Sponsor

Acepodia Biotech, Inc.